Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Liraglutide Market Today And What Is Its Future Size?

The market size for liraglutide has seen significant growth in the past few years. The market value is expected to rise from $6.38 billion in 2024 to $6.88 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%. The growth during the historical period can be linked to an increase in the diagnosis of type 2 diabetes, an escalation in obesity rates, numerous clinical trials, heightened awareness of complications related to diabetes, and ongoing advancements in drug delivery systems.

The market for liraglutide is foreseen to experience robust growth in the coming years, anticipated to rise to a value of “$9.45 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 8.3%. The prediction for this growth is primarily due to factors such as expanding insurance coverage and reimbursement practices, development in healthcare facilities, rising awareness and educational campaigns, increasing elderly population, and the growing occurrences of diabetes. Key trends noted for the forecast period encompasses the application of artificial intelligence and machine learning, the surge in demand for wearable technology, integration with continuous glucose monitoring, advancements in biotechnology, and the evolution of digital health platforms.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18659&type=smp

Which Key Factors Are Fueling Growth In The Liraglutide Market?

The rise in the number of individuals with diabetes is anticipated to spur the expansion of the liraglutide market. Diabetes is a persistent disorder characterized by the body’s inability to correctly maintain blood sugar levels, this can be a result of an insufficient production of insulin or ineffective use of the insulin. Escalating rates of diabetes are attributed to factors such as inactive lifestyles, unhealthy eating habits, and the global emergence of obesity. Medications for diabetes like liraglutide are effective as they emulate the performance of the hormone GLP-1, which bolsters insulin secretion, reduces blood sugar levels, and stimulates weight loss, subsequently assisting in the control of type 2 diabetes. For example, as per a March 2024 report by the Government of the United Kingdom, a UK-based information website revealed that in March 2023, the percentage of individuals with type 1 diabetes in England receiving all 8 care processes at GP practices participating in the NDA rose to 43.8% from 35.2% the previous year. Therefore, the growing diabetic population serves as a driving factor for the liraglutide market’s expansion.

What Segmentation Insights Are Provided In The Liraglutide Market Research?

The liraglutide market covered in this report is segmented –

1) By Brands: Victoza, Saxenda

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies

3) By Type Of Application: Diabetes Treatment, Weight Management

4) By End-Users: Hospitals And Clinics, Homecare Settings

Subsegments:

1) By Victoza: Type 2 Diabetes Treatment Or Weight Management

2) By Saxenda: Weight Loss Treatment Or Obesity Management

Which Notable Trends Are Transforming The Liraglutide Market Outlook?

Leading firms in the liraglutide market are focusing on the creation of innovative products such as generic GLP-1, aiming to increase the range of treatments available and cater to the need for cost-effective options. When patents for the original branded medications expire, generic GLP-1, which are versions of GLP-1 receptor agonists, are created, offering more affordable alternatives for managing conditions like type 2 diabetes and obesity. For example, Teva Pharmaceutical Industries Ltd., a pharmaceutical company based in Israel, launched the first generic GLP-1, comparable to Victoza, in the U.S. market in June 2024, thereby fulfilling the growing demand for such treatments. Adults and children aged 10 years and older with type 2 diabetes are recommended liraglutide injections for better blood sugar control and to decrease the probability of cardiovascular events in adults with type 2 diabetes and existing cardiovascular diseases.

Which Firms Are Driving Innovation Within The Liraglutide Market?

Major companies operating in the liraglutide market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Liraglutide Market?

North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=18659&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model